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There is a genetic contribution to fetal alcohol spectrum disorders
(FASD), but the identification of candidate genes has been elusive.
Ethanol may cause FASD in part by decreasing the adhesion of the
developmentally critical L1 cell adhesion molecule through interac-
tions with an alcohol binding pocket on the extracellular domain.
Pharmacologic inhibition or genetic knockdown of ERK2 did not
alter L1 adhesion, but markedly decreased ethanol inhibition of L1
adhesion in NIH/3T3 cells and NG108-15 cells. Likewise, leucine re-
placement of S1248, an ERK2 substrate on the L1 cytoplasmic do-
main, did not decrease L1 adhesion, but abolished ethanol inhibition
of L1 adhesion. Stable transfection of NIH/3T3 cells with human L1
resulted in clonal cell lines in which L1 adhesion was consistently
sensitive or insensitive to ethanol for more than a decade. ERK2
activity and S1248 phosphorylationwere greater in ethanol-sensitive
NIH/3T3 clonal cell lines than in their ethanol-insensitive counter-
parts. Ethanol-insensitive cells became ethanol sensitive after in-
creasing ERK2 activity by transfection with a constitutively active
MAP kinase kinase 1. Finally, embryos from two substrains of
C57BL mice that differ in susceptibility to ethanol teratogenesis
showed corresponding differences in MAPK activity. Our data sug-
gest that ERK2 phosphorylation of S1248 modulates ethanol inhibi-
tion of L1 adhesion by inside-out signaling and that differential
regulation of ERK2 signaling might contribute to genetic suscepti-
bility to FASD. Moreover, identification of a specific locus that reg-
ulates ethanol sensitivity, but not L1 function, might facilitate the
rational design of drugs that block ethanol neurotoxicity.
Prenatal alcohol exposure causes fetal alcohol spectrum dis-orders (FASD) in up to 2–5% of school-age children and is the
leading preventable cause of mental retardation in the Western
world (1, 2). The prevalence and presentation of FASD are
influenced by the quantity, frequency, and timing of drinking and
are modified by a variety of environmental, nutritional, epigenetic,
and genetic factors (3–7). The observation that there is greater
concordance for fetal alcohol syndrome (FAS) in monozygotic
twins than in dizygotic twins suggests that there are susceptibility
genes for FASD (8); however, their identification remains elusive.
The identification of molecular pathways that regulate sensitivity
to ethanol teratogenesis would be helpful in the search for FASD
susceptibility genes.
One potentially important target of ethanol in the pathogen-
esis of FASD is the developmentally critical immunoglobulin
neural cell adhesion molecule, L1. The homophilic binding of L1
molecules on adjacent cells mediates neuronal migration, axon
guidance, and axon fasciculation (9)—developmental events that
are disrupted in FASD (10-12). Mutations in the human L1 gene
cause brain lesions and neurological abnormalities. Some of
these mutations also disrupt L1 homophilic binding (13–16). We
noted that brain lesions in children with FASD resemble those
of children with mutations in the gene for L1 and demonstrated
that concentrations of ethanol attained after just one or two
drinks inhibit L1 adhesion in cerebellar granule neurons, neural
cell lines, and NIH/3T3 fibroblasts (17-19). Importantly, drugs
that block ethanol inhibition of L1 adhesion also prevent ethanol
teratogenesis in mice (20–25).
L1 adhesion is not universally inhibited by ethanol. For ex-
ample, ethanol does not inhibit the adhesion of human L1 (hL1)
when expressed in myeloma cells or Drosophila S2 cells (26, 27).
Even clonal NIH/3T3 cell lines derived from a single transfection
with hL1 have shown either an ethanol-sensitive or ethanol-
insensitive phenotype over multiple passages and many years
(19). These findings suggest that cell-specific factors regulate the
sensitivity of L1 to ethanol. The characterization of these factors
might prove valuable in identifying candidate genes that govern
susceptibility to ethanol teratogenesis.
L1 homophilic binding is mediated by its extracellular domain
(ECD), which comprises six Ig and five fibronectin type III (Fn)
repeats (9). Homophilic binding is potentiated by the folding of the
L1-ECD into a horseshoe structure in which the Ig1 and Ig4
domains lie opposed to each other (28–30). Using photolabeling,
we demonstrated the interaction of alcohols with a binding pocket
at this functionally important Ig1–Ig4 domain interface (31).
Mutation of a single alcohol binding residue, Glu-33 on Ig1, did
not reduce L1 adhesion, but markedly altered the pharmacology of
alcohol inhibition of L1 adhesion (31). These findings suggest that
subtle changes in the conformation of an alcohol binding pocket
can significantly alter alcohol inhibition of L1 adhesion.
If ethanol inhibits L1 adhesion by interacting with an extracel-
lular binding pocket, how, then, might intracellular events regulate
these extracellular interactions? The L1 cytoplasmic domain
(L1-CD) is highly conserved across species and contains numer-
ous sites for phosphorylation by casein kinase II, p90 ribosomal S6
kinase, extracellular signal-regulated kinase 2 (ERK2) [a member
of the mitogen-activated protein kinase (MAPK) family], pp60c-
src, chicken embryonic kinase 5, and potentially other kinases (32–
35). Phosphorylation of the L1-CD regulates the conformation
and function of the extracellular domain (ECD) (36, 37), a phe-
nomenon known as “inside-out” signaling and could conceivably
modify the conformation of the alcohol binding pocket in the
L1-ECD. Here, we show that L1 sensitivity to ethanol is regulated
by phosphorylation of S1248, an ERK2 substrate on the L1-CD.
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Furthermore, differences in MAPK activity and S1248 phos-
phorylation determine the ethanol-sensitive or ethanol-insensitive
phenotype of clonal L1-expressing NIH/3T3 cells. Finally, two
substrains of C57BL mice that differ in susceptibility to ethanol
teratogenesis show corresponding differences in MAPK activity.
Results
Ethanol Does Not Inhibit Adhesion of the Purified L1-ECD. To eval-
uate the intrinsic sensitivity of the L1-ECD to ethanol, we studied
the effects of ethanol on the adhesive properties of the purified
L1-ECD attached to microspheres. Microspheres coated with
mouse L1 (mL1)-ECD showed significantly greater aggregation
than microspheres coated with BSA (Fig. 1). High concen-
trations of ethanol (100 mM) had no effect on the aggregation of
microspheres coated with either BSA or mL1. These findings
imply that cellular presentation is necessary for the L1-ECD to
assume an ethanol-sensitive conformation.
Inhibition of ERK2 Blocks Ethanol Inhibition of L1 Adhesion. The use
of computational selection and candidate gene prioritization iden-
tified MAPK among leading candidate genes for susceptibility to
FAS (3). Therefore, we studied ERK1/2 modulation of ethanol
sensitivity in two model systems in which ethanol always inhibits L1
adhesion: 2A2-L1s, an NIH/3T3 clonal cell line that stably expresses
hL1, and NG108-15, a neural cell line that expresses mL1 after
treatment with bone morphogenetic proteins (17, 19, 23, 38, 39).
Pretreatment for 1 h with PD98059, a noncompetitive inhibitor of
MAP kinase kinase 1 (MEK1), reduced ERK1/2 activity in 2A2-L1s
(Fig. S1). PD98059 caused a dose-dependent reduction in ethanol
inhibition of L1 adhesion in 2A2-L1s and NG108-15 cells (Fig. 2A
and Table S1). In contrast, PD98059 did not alter L1 adhesion,
except for a small decrease at the highest dose in NG108-15 cells.
Similarly, transfection with an ERK2 siRNA had no effect on L1
adhesion but significantly reduced ethanol inhibition of L1 adhe-
sion in both 2A2-L1s and NG108-15 cells (Fig. 2B). These findings
indicate that inhibition of ERK2 activity can block ethanol in-
hibition of hL1 and mL1 adhesion in fibroblast and neural cell
lines, respectively, without modulating L1 adhesion.
ERK2 Phosphorylation of S1248 on the L1 Cytoplasmic Domain Is
Necessary for Ethanol Sensitivity. There are two known ERK2
phosphorylation sites at S1204 and S1248 on the hL1-CD (40). To
determine whether phosphorylation of these sites is necessary for
L1 sensitivity to ethanol, we transiently transfected NIH/3T3 cells
with plasmids containing hL1 constructs in which S1204, S1248,
or both were mutated to leucine to prevent phosphorylation (32).
Cells expressing L1-S1204L showed normal L1 expression and
adhesion (Fig. S2) and a statistically insignificant reduction in
sensitivity to ethanol (Fig. 2 C and D). Cells expressing
L1-S1248L or L1-S1204L/S1248L also showed normal L1 expres-
sion and adhesion but were insensitive to high concentrations of
ethanol (100 mM). These data provide compelling evidence that
ERK2 phosphorylation of the L1-CD is necessary for ethanol in-
hibition of L1 adhesion.
ERK2 Activity Differs in Ethanol-Sensitive and Insensitive Cell Lines.
We next asked whether differences in ERK2 activity could ac-
count for the ethanol-sensitive or ethanol-insensitive phenotype
of stably transfected hL1-expressing NIH/3T3 clonal cell lines
(19). The normalized ratio of phosphorylated ERK1/2 (pERK1/2)
to total ERK1/2, as measured by ELISA, was significantly higher
in two ethanol-sensitive clonal cell lines (0.94 ± 0.01) than in
three ethanol-insensitive clonal cell lines (0.70 ± 0.03, n = 18,
P < 0.0001) (Fig. 3A). Furthermore, ERK1/2 activity, as mea-
sured by the phosphorylation of myelin basic protein, was sig-
nificantly higher in the ethanol-sensitive 2A2-L1s cell line (8.2 ±
0.4 OD units per mg of protein, n = 4) than in the ethanol-
insensitive 3C3-L1i cell line (5.7 ± 0.4 OD units per mg of pro-
tein, n = 4, P = 0.0057) (Fig. S3B). Of note, treatment of 2A2-L1s
cells with 100 μM PD98059, which blocked ethanol sensitivity,
also reduced ERK1/2 activity to levels observed in 3C3-L1i cells
(Figs. S1A and S3B). Hence, constitutive differences in ethanol
sensitivity in L1-expressing clonal cell lines are associated with
differences in ERK1/2 activity.
L1-S1248 Phosphorylation Is Greater in Ethanol-Sensitive than in
Ethanol-Insensitive NIH/3T3 Cells. If L1-S1248 phosphorylation is
necessary for ethanol sensitivity of L1 and differences in ERK2
activity account for the differences in the ethanol sensitivity of
2A2-L1s and 3C3-L1i cells, then levels of S1248 phosphorylation
(pS1248) should be higher in 2A2-L1s than in 3C3-L1i cells. To
test this hypothesis, we developed a rabbit antiserum, dp-S1248,
that preferentially recognizes an oligopeptide (L1-D1242-L1256)
Fig. 1. Ethanol does not inhibit the adhesion of beads coated with the
purified L1-ECD. (A) Representative phase contrast photomicrographs of
1-μm polystyrene beads coated with purified L1-ECD or BSA after agitation
for 30 min in the absence or presence of 100 mM ethanol. (B) Mean ± SEM
number of particles ≥1 μm per image from three independent experiments.
Fig. 2. ERK2 phosphorylation of S1248 is necessary for ethanol inhibition of
L1 adhesion. (A) PD98059 dose dependently blocks ethanol inhibition of L1
adhesion in 2A2-L1s cells and BMP-7–treated NG108-15 cells. (B) Effect of
ERK2-siRNA transfection on ethanol inhibition of L1 adhesion in BMP-7–
treated NG108-15 and 2A2-L1s cells. Bars represent results of treatment with
Lipofectamine, the transfection reagent (Control), control-siRNA, or ERK2-
siRNA. **P < 0.01, n = 4; ***P < 0.001, n = 8. (C and D). Effect of ethanol on
cell adhesion in WT and mutant-L1–expressing NIH/3T3 cells. Constructs
containing L1-WT, L1-S1204S, L1-S1248S, or L1-S1204S/L1248S were tran-
siently transfected in NIH/3T3 cells as shown in Fig. S2. (D) Ethanol inhibition
of cell adhesion calculated from paired experiments shown in C. Data shown
are the mean ± SEM for percent cell adhesion (C) or percent ethanol in-
hibition of cell adhesion (D) in 9–14 independent experiments; **P = 0.0020,
***P < 0.0001.
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containing nonphosphorylated versus phosphorylated L1-S1248
(Fig. S4) and immunoprecipitates from cells transfected with
L1-S1248L versus wild-type L1-S1248 (Fig. 3 B and C). Antiserum
dp-S1248 immunolabeling was 46.7 ± 5.1% lower (P < 0.0001,
n = 8) in L1 immunoprecipitates from 2A2-L1s cells than in
those from 3C3-L1i cells. This dp-S1248 immunolabeling was
preferentially inhibited when antibody was absorbed with the
nonphosphorylated oligopeptide compared with the phosphory-
lated oligopeptide (Fig. S4 C and D). These findings suggest that
S1248 phosphorylation levels are higher in ethanol-sensitive
2A2-L1s cells than in ethanol-insensitive 3C3-L1i cells.
Ethanol-Insensitive Phenotype Can Be Transformed by Increasing
ERK1/2 Activity. If constitutive ERK1/2 activity determines the
sensitivity of L1 to ethanol and inhibition of ERK1/2 activity
blocks ethanol inhibition of L1 adhesion, then increasing ERK1/2
activity should render ethanol-insensitive cells sensitive to etha-
nol. To test this hypothesis, we transiently transfected the 2A2-L1s
and 3C3-L1i cell lines with constitutively active MEK1 (MEK1*)
(41, 42), the kinase that phosphorylates ERK1/2. Transfection
with MEK1* significantly increased ERK1/2 phosphorylation in
3C3-L1i cells to levels observed in control 2A2-L1s cells, but did
not increase ERK2 phosphorylation in 2A2-L1s cells (Fig. S5).
MEK1* transfection did not alter L1 adhesion in either cell line
and did not enhance ethanol inhibition of L1 adhesion in 2A2-L1s
cells (Fig. 3 D and E). However, after transfection with MEK1*,
ethanol robustly inhibited L1 adhesion in 3C3-L1i cells (43.7 ±
5.3% inhibition; P = 0.0005, n = 4–14). These findings support the
hypothesis that ERK2 phosphorylation of L1 modulates its sen-
sitivity to ethanol.
ERK1/2 Activity Differs in Mouse Substrains That Differ in Sensitivity
to Ethanol Teratogenesis. We next asked whether ERK1/2 activity
correlates with sensitivity to ethanol teratogenesis in animals.
C57BL/6J (6J) mice from the Jackson Laboratory and C57BL/
6Nhsd (6N) mice from Harlan Laboratories are derived from the
same strain but have diverged slightly after hundreds of gen-
erations of inbreeding. Both substrains were administered one
dose of ethanol (2.9 g/kg) at the beginning of gestational day (GD)
7 and another dose 4 h later. This well-established ethanol ex-
posure paradigm induces ocular defects similar to those observed
in children with FAS (43). Examination of GD 14 fetuses from
ethanol-exposed dams revealed right ocular defects in 50.9% of 6J
mice (n = 55) and 28.2% of 6N mice (n = 71; P = 0.0104, Fisher’s
exact test) and left ocular defects in 41.8% of 6J mice and 11.3%
of 6N mice (P = 0.0001). Blood alcohol concentrations 30 min
after the second injection did not differ significantly between the
two substrains (6J: 420 ± 18 mg/dL, n = 7; 6N: 403 ± 33 n = 5; P =
0.63). These data demonstrate that 6J mice are significantly more
susceptible to the teratogenic effects of early ethanol exposure than
6N mice. Of note, levels of pERK1/2, measured by ELISA, were
31% higher in GD 10 embryos from untreated, ethanol-sensitive 6J
mice (114 ± 4 relative units) than in those from the comparably
staged less sensitive 6N mice (87 ± 6 relative units; n = 26; P =
0.0004, ANOVA) (Fig. 4). These differences in ERK1/2 activity
are comparable to those measured in ethanol-sensitive and eth-
anol-insensitive NIH/3T3 clonal cell lines (Fig. 3A and Fig. S3B).
Discussion
A major finding of this work is that ethanol inhibition of L1
adhesion has two requirements: L1 must be expressed in cells
and must be phosphorylated by ERK2 at S1248 in the L1-CD.
Ethanol had no effect on adhesion mediated by beads coated
Fig. 3. ERK1/2 activity and phosphorylation of S1248 determine ethanol sen-
sitivity in L1-expressing clonal NIH/3T3 cell lines. (A) Ratio of pERK1/2 to ERK1/2,
determined by ELISA, n = 13–18. Pooled values of ERK1/2 phosphorylation for
the two ethanol-sensitive cell lines were significantly higher than in the three
ethanol-insensitive cell lines (F = 16.0; P < 0.0001). (B and C) L1 was immuno-
precipitated from 2A2-L1s and 3C3-L1i cells or NIH/3T3 cells transiently trans-
fected with wild-type L1 (WT) or L1-S1248L usingmAb 5G3. Immunoblots were
prepared by using polyclonal antibody SC-1508, which recognizes the L1-CD,
and antiserum dp-S1248, which preferentially recognizes the nonphosphor-
ylated form of L1-S1248. The ratio of bands labeled by SC-1508 and dp-S1248
was normalized in each gel to values from NIH/3T3 cells transiently transfected
with wild-type L1 (WT) to control for variable exposure on individual Western
blots. (B) Representative gel showing immunolabeling of L1 immunoprecipi-
tated from NIH/3T3 cells transiently transfected with wild-type L1 (WT) or
L1-S1248L (S1248L) and from stably transfected 2A2-L1s (2A2) and 3C3-L1i (3C3)
cells. IP indicates the immunoprecipitating antibody 5G3; IB indicates the anti-
bodies dp-S1248 and SC-1508 used for the immunoblot. (C) Bars represent the
mean ± SEM ratio of dp-S1248 (nonphosphorylated L1-S1248) to SC-1508 (total
L1) immunolabeling from eight independent experiments. Lower values in-
dicate higher levels of phosphorylation. *P = 0.02; **P = 0.003. (D) The effect of
transfection of a constitutively active MEK1 (MEK1*) on L1 adhesion in the
absence and presence of 100 mM ethanol in 2A2-L1s cells, *P = 0.0350, n = 4;
**P = 0.0017, n = 8; ***P < 0.0001, n= 4; and in 3C3-L1i cells, ***P < 0.0001, n=
14. (E) Effect ofMEK1* transfection in 2A2-L1s (PolyFect,n= 4;MEK1,n= 8) and
3C3-L1i cells (PolyFect, n = 4; MEK1, n = 14) on the percentage of ethanol in-
hibition of L1 adhesion calculated from the indicated number of paired
experiments. ***P = 0.0005.
Fig. 4. ERK1/2 phosphorylation is higher in C57BL/6J than in C57BL/6N
mouse substrains. Total ERK1/2 and pERK1/2 were measured by ELISA in
GD10 embryos from the ethanol-sensitive 6J mice (n = 26) and less-sensitive
6N mice (n = 22). Each point represents the pERK1/2 to ERK1/2 ratio for an
individual embryo normalized to values from a pooled sample of GD10 em-
bryos from both substrains. Also shown is the mean ± SEM for the pERK1/2
to ERK1/2 ratios for each group, ***P = 0.0004.

















with the purified L1-ECD. It appears likely that presentation of
purified L1 outside of a cellular context disrupts the specific con-
formation of the alcohol binding pocket that is required for ethanol
inhibition of L1 adhesion. This observation is consistent with our
recent report that an alcohol binding pocket at the Ig1–Ig4 interface
of L1 is susceptible to minor structural modifications (31, 44).
Ethanol inhibition of L1 adhesion in cells was strongly inhibited
by 1 μM PD98059, a concentration that selectively inhibits MEK1
(45), the kinase that phosphorylates and activates ERK1/2. The
effect of PD98059 was evident at similar concentrations in fibro-
blasts expressing hL1 and neural cells expressing mL1, indicating
that MEK1 inhibition affects L1 sensitivity to ethanol across mul-
tiple cell lineages. Although kinase inhibitors are never perfectly
selective for individual kinases, targeted knockdown of ERK2 also
reduced L1 sensitivity to ethanol. Taken together, these experi-
ments indicate that ERK2 activation is necessary for ethanol in-
hibition of L1 adhesion, but do not establish whether ERK2 acts by
directly phosphorylating the L1-CD or by phosphorylating other
proteins that interact with L1 (9). To address this question, we
studied NIH/3T3 cells transiently transfected with L1 constructs in
which S1204, S1248, or both were mutated to leucine residues,
thereby preventing phosphorylation of the two known ERK2 sub-
strates on the L1-CD. The S1204L mutation did not significantly
reduce ethanol inhibition of L1 adhesion, whereas the S1248L or
the S1204L/S1248L mutations abolished ethanol inhibition of L1
adhesion. These findings indicate that ERK2 regulates L1 sensi-
tivity to ethanol by directly phosphorylating S1248 in the L1-CD.
The cytoplasmic domain is not necessary for the adhesive
properties of neuroglian, the Drosophila L1 homolog (46); how-
ever, modifications to the neuroglian-CD can influence its adhe-
sion through inside-out signaling (36). Phosphorylation of the
L1-CD has also been shown to modify the structure and function
of the L1-ECD. Chen et al. (35) reported that phosphorylation of
T1172 in the L1-CD altered L1 binding to integrins and masked
or unmasked specific epitopes in theL1-ECD.Of note, L1 adhesion
in the absence of ethanol was not altered by pharmacological in-
hibition of MEK1, ERK2 knockdown, or mutation of S1248 to
leucine, although each of these interventions reduced or abolished
ethanol inhibition of L1 adhesion. Presumably, dephosphophor-
ylation of S1248 alters the conformation of an alcohol binding
pocket on the L1-ECD sufficiently to prevent the interaction of
ethanol with L1, while preserving structural features of the L1-ECD
that are necessary for L1 homophilic adhesion (Fig. 5).
Phosphorylation of S1248 is necessary for ethanol inhibition of
L1 adhesion; however, our data do not exclude a role for phos-
phorylation of other residues in the L1-CD in regulating ethanol
sensitivity. Both T1247 and S1248 are required for L1-mediated
ERK activation and cell motility (47), and conceivably a combina-
tion of phosphorylation and dephosphorylation of a variety of cy-
toplasmic residues is required for ethanol inhibition of L1 adhesion.
Hence, a variety of kinases or phosphatases could separately in-
fluence the ethanol sensitivity of L1 by modulating the phosphor-
ylation state of key residues in the L1-CD. The identification of loci
that regulate ethanol sensitivity, but not L1 function, might facili-
tate the rational design of drugs that block ethanol neurotoxicity.
Shortly after reporting that ethanol inhibits L1 adhesion, we
learned that not all L1-expressing cells are sensitive to ethanol. A
series of cell lines that had been clonally selected after the
transfection of a single NIH/3T3 stock with hL1 (19) consistently
expressed either an ethanol-sensitive or ethanol-insensitive phe-
notype over more than a decade. L1 expression and L1 adhesion
did not differ between ethanol-sensitive and ethanol-insensitive
cells; however, purified Fab fragments from a polyclonal antibody
blocked L1 adhesion in the ethanol-sensitive cells, but not in the
ethanol-insensitive cells (19). We speculated that the L1-ECD
required a particular conformation for ethanol sensitivity and that
the conformation of the L1-ECD in ethanol-insensitive cells
masked epitopes recognized by this polyclonal antibody (19).
Our current data suggest that constitutive differences in ERK2
activity contribute to the ethanol-sensitive or ethanol-insensitive
phenotype of these clonal cell lines. ERK1/2 activity was approxi-
mately one-third higher in two ethanol-sensitive cell lines than in
three ethanol-insensitive cell lines. These findings could not be
attributed to differences in cell density or cell–cell interactions
before assay (48), because ethanol-sensitive and ethanol-insensitive
cell lines were harvested at the same density. These modest in-
creases in ERK1/2 activity were amplified at the level of substrate
phosphorylation; S1248 phosphorylation in ethanol-sensitive 2A2-
L1s cells was approximately double that of ethanol-insensitive 3C3-
L1i cells. Finally, the long-standing ethanol-insensitive phenotype of
3C3-L1i cells was transformed to an ethanol-sensitive phenotype by
increasing ERK2 activity through the expression of a constitutively
active MEK1* molecule. These findings indicate that the ERK1/2
signaling pathway is an important determinant of L1 sensitivity to
ethanol in clonal cell lines. Differential phosphorylation of S1248
and other cytoplasmic residues might also explain the inability of
ethanol to inhibit L1 adhesion in myeloma and insect cells (26, 27).
To demonstrate the relevance of our findings to ethanol tera-
togenesis, we also identified differences in susceptibility to etha-
nol teratogenesis in two highly related mouse substrains. Like our
clonal cell lines, the two substrains of C57BL/6 mice were derived
from a common stock and likely differed only minimally in their
genetic and epigenetic profiles. The C56BL/6J mice proved more
susceptible to ethanol-induced ocular defects than their C56BL/
6N counterparts. Blood alcohol levels were comparable in the two
strains, indicating that their differential susceptibility to ethanol
teratogenesis was not related to differences in ethanol pharma-
cokinetics. In contrast, ERK1/2 activity was significantly higher in
the more sensitive C56BL/6J mice than in the less sensitive
C57BL/6N mice. Thus, increased ERK1/2 activity is associated
with increased ethanol inhibition of L1 adhesion in clonal cell
lines and increased susceptibility to ethanol teratogenesis in mice.
Taken together, these data suggest that genes for ERK2 and the
Fig. 5. ERK2 phosphorylation of S1248 in the L1-CD is necessary for ethanol
inhibition of L1 adhesion. (A) The L1 extracellular domain (L1-ECD) folds into
a horseshoe structure that favors L1 adhesion. An alcohol binding pocket has
been identified at the interface between Ig1 and Ig4, and ethanol appears to
inhibit L1 adhesion by disrupting this horseshoe structure (31, 44). Phos-
phorylation of S1248 by ERK2 is proposed to induce a conformational change
in the L1-ECD (inside-out signaling) that favors ethanol binding within this
pocket. (B) PD98059, an inhibitor of MEK1/2, or knockdown of ERK2 using
siRNA decrease ERK2 phosphorylation of S1248 and reduce ethanol inhibition
of L1 adhesion. Likewise, mutation of S1248 to L1248 prevents phosphory-
lation at this site and abolishes ethanol inhibition of L1 adhesion.
5686 | www.pnas.org/cgi/doi/10.1073/pnas.1221386110 Dou et al.
signaling molecules that regulate ERK2 activity might influence
genetic susceptibility to FASD. The identification of additional
regulatory pathways for L1 sensitivity to ethanol might further
expand this repertoire of candidate genes.
Materials and Methods
Bead Aggregation Assay for L1 Adhesion.Mouse L1-ECD-Fc (mL1-Ig1-6-Fn3-1–5-
Fc) was prepared as described (44, 49) and digested with AcTEV Protease
(Invitrogen) to remove Fc. Polybead Carboxylate Blue Dyed 1-μmmicrospheres
(Polysciences Inc.)were coatedwithmL1-ECDprotein at a ratio of 8× 109 beads
per μg of L1 protein or 8 × 109 beads per 3 μg of BSA using the Glutaraldehyde
Kit (Polysciences Inc.), according to the manual. Beads were suspended in PBS
in 96-well plates (1 × 108 beads per 100 μL of PBS for each well) in the absence
and presence of 100 mM ethanol and agitated at 60 rpm for 30 min at room
temperature on a rotary shaker (Stovall Life Science). Plates were set for 5 min
onan inverted-stageNikon/Eclipse-MA100microscope to allowbeads to settle,
and images were acquired at 200× magnification by using Openlab software
(PerkinElmer). The total number of particles ≥1.0 μm in each image was ana-
lyzed with National Institutes of Health ImageJ software by using the particle
analysis function (50).
Cell Culture. We studied five stably transfected hL1-expressing NIH/3T3 clonal
cell lines, including two—2A2-L1s and 2B2-L1s—in which ethanol inhibited L1
adhesion (ethanol-sensitive, denoted by L1s) and three—3C3-L1i, 50FE-L1i and
3E2-L1i—in which ethanol did not inhibit L1 adhesion (ethanol insensitive,
denoted by L1i); cells were cultured as described (18, 19). In other experiments,
NIH/3T3 cellswere transiently transfectedwithplasmidDNAcontainingWT-L1,
mutant L1, or MEK1* plasmid, (Upstate Biotech) and cultured for 24 h before
use in experiments (31). The neuroblastoma× glioma hybrid cell lineNG108-15
was cultured as described (38, 51). Three days before cell adhesion assays, cells
were switched to serum-free medium (51) with or without 10 ng/mL BMP-7
(Creative BioMolecules) to induce the expression ofmL1 (17, 39, 51). TheMEK1
inhibitor PD98059 was dissolved in DMSO and applied directly into culture
medium to the designated final concentration. The L1-S1204L, L1-S1248L, and
L1-S1204L/S1248L mutants were kind gifts from B. Schmitz (Department of
Biochemistry, University of Bonn, Bonn, Germany) (32).
siRNA Transfection of NIH/3T3 and NG108-15 Cells. Cells were transfected with
ERK2-siRNA and negative control siRNA (Thermo Scientific Dharmacon RNAi
Technologies) using Lipofectamine 2000 (Invitrogen). Forty-eight hours after
transfection, the cells were harvested for cell adhesion assays or to examine
ERK2 expression with immunofluorescence microscopy and Western blotting
by using a mouse anti-ERK2 mAb (clone 05–157, Millipore).
Protein Analysis for Cultured Cells. Cells were grown to 75–85% confluence,
harvested in PBS plus 2 mM EDTA, and pelleted by centrifugation. Cells were
resuspended in Nonidet P-40 lysis buffer [150 mM NaCl, 50 mM Tris at pH 8.0,
and 1.0% (vol/vol) Nonidet P-40] supplemented with 1/100 (vol/vol) Protease
Arrest and 1/100 (vol/vol) Phosphatase Inhibitor Mixture (Calbiochem), in-
cubated on ice for 5 min, and centrifuged at 4 °C at 16,000 × g for 15 min to
remove the insoluble fraction. Protein was separated and analyzed by
Western blot using goat polyclonal antibody SC-1508 for L1 (31), rabbit
polyclonal anti-pERK1/2 antibody (SC-23759-R), mouse monoclonal anti-
ERK1/2 antibody (SC-135900) (all from Santa Cruz Biotechnology), and rabbit
polyclonal ab11317 for γ-tubulin (Abcam).
Mouse Embryo Collection and Assay. The 6J mice were obtained from The
Jackson Laboratories, and the 6N were obtained from Harlan Laboratories.
The mice were bred by placing one or two females with a single male of the
same substrain for 1 h and then examined for the presence of a copulation
plug. The beginning of the 1-h mating period in which a copulation plug was
found was designated as GD 0. On GD 10, the dams were euthanized by CO2
asphyxiation, and the embryos were removed and dissected from the ex-
traembryonic tissue. After staging each embryo by counting the number of
somite pairs, embryos were quickly frozen and stored in PBS with 5 mM
EDTA at −80 °C. Only embryos having 26–30 somites were used for analyses.
These embryos were thawed on ice and placed directly in 200–300 μL of
Nonidet P-40 lysis buffer with the protease and phosphatase inhibitors
above, lysed by vigorous pipetting and vortexing, and centrifuged at
16,000 × g to collect supernatant for pERK1/2 and ERK1/2 analysis below. All
animal use protocols were approved by the University of North Carolina at
Chapel Hill Institutional Animal Care and Use Committee (IACUC).
Production of an Antiserum, dp-S1248, to the Nonphosphorylated Form of
S1248. A rabbit antiserum was generated by Antagene by immunization
with L1-D1242-L1256 [Cys-DSSGAT(p)SPINPAVAL], a phosphopeptide derived
from the L1-CD. The antiserumwas passed through a phosphopeptide column
[Cys-DSSGAT(p)SPINPAVAL], and the eluent was then loaded onto the corre-
sponding nonphosphopeptide column. Specificity of the antisera for S1248 or
pS1248 was tested by using dot blots impregnated with serial dilutions of the
immunizing phosphorylated and nonphosphorylated peptides. Dot blots were
air dried on a PVDF membrane and blocked with 3% (wt/vol) BSA in TBST,
incubated with HRP-conjugated secondary antibody, and visualized by using
chemiluminescence (Millipore) (31). Theeffluent from thenonphosphopeptide
column preferentially labeled the nonphosphorylated peptide; this antiserum
is referred to as dp-S1248. The flow-through from the nonphosphopeptide
column did not preferentially label the phosphorylated peptide.
ERK1/2 Phosphorylation and Activity Assays. Phospho-ERK1/2 (pERK1/2) and
total ERK1/2 in whole-cell lysates from cultured cells and mouse embryos were
measured with pERK1/2 (pThr185/pTyr187) and ERK1/2 ELISA kits, respectively
(Sigma-Aldrich), according to the manuals. Absorbance at 450 nm was nor-
malized to protein content of the whole-cell lysates, as determined by the
Bradfordmethod (31), and expressed as mean ± SEMoptical density (O.D.) per
mg of protein. Alternatively, pERK1/2 levels were measured by immunoblot-
ting of whole-cell extracts with mouse polyclonal antibody SC23759 against
pERK1/2 and mouse mAb SC135900 against total ERK1/2 (Santa Cruz). ERK1/2
activity in 2A2-L1s and 3C3-L1i cell lines was measured by using a MAPK (ERK1/
2) Activity Assay Kit (Millipore), which assays the phosphorylation of myelin
basic protein (MBP) by ERK1/2 in total cell lysates. ERK1/2 activitywas expressed
as O.D. units at 450 nm per mg of protein of total cell lysates, and the relative
level of ERK1/2 activity in 2A2-L1s and 3C3-L1i cell lines was calculated as the
mean ± SEM ratio of ERK1/2 activities in the two cell lines.
Cell Surface Expression of L1. L1 immunostaining was performed in attached
live cells and visualized by using confocal microscopy, as described (31), using
5G3 mAb, which recognizes an epitope overlapping the Ig1 and Ig2 domains
of L1 (35). Cell surface expression of L1 was quantified by flow cytometry
with mAb 5G3 (31). Data were presented as the geometric mean ± SEM.
Cell Aggregation Assay. L1-mediated cell–cell adhesion (L1 adhesion) in NIH/
3T3 cells andNG108-15 cells was determined by separating cells into single-cell
suspensions, agitating, and measuring the percentage of adherent cells using
phase contrast microscopy, as described (19, 31, 38). For comparisons of L1
adhesion between ethanol-sensitive and ethanol-insensitive cell lines, all cells
were harvested at the same density.Weused 100mMethanol, a concentration
much higher than the half-maximal concentration of ∼5 mM (18, 31), to
demonstrate the robustness of the antagonistic effects of kinase inhibitors,
gene knockdown, and L1 pointmutation on ethanol inhibition of L1 adhesion.
Statistical Analysis. Data are expressed as mean ± SEM, except as noted.
Statistical analysis was performed by using the ANOVA with Tukey’s cor-
rection for multiple comparisons and two-tailed paired t tests using Prism 5
(Graphpad Software). Statistical significance was defined as P < 0.05.
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